📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility. (2013)

First Author: Penn H

Attributed to: MICA: Evaluation of the selective endothelin A-receptor antagonist zibotentan as a treatment for renal disease in systemic sclerosis (scleroderma) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/qjmed/hct111

PubMed Identifier: 23696678

Publication URI: http://europepmc.org/abstract/MED/23696678

Type: Journal Article/Review

Volume: 106

Parent Publication: QJM : monthly journal of the Association of Physicians

Issue: 9

ISSN: 1460-2393